EXHIBIT 23.3

                         INDEPENDENT AUDITORS' CONSENT


We consent to the incorporation by reference in this registration statement of
Curis Inc., on Form S-8 relating to the Curis, Inc. 2000 Director Stock Option
Plan of our report dated February 15, 2000 (which expresses an unqualified
opinion and includes an emphasis paragraph referring to the merger with
Ontogeny, Inc., and Reprogenesis, Inc. to form Curis, Inc.) relating to the
Consolidated Financial Statements of Creative BioMolecules, Inc., included in
the Registration Statement No. 333-32446, Amendment No.5, on Form S-4 filed by
Curis Inc. with the Securities and Exchange Commission on June 16, 2000.


/s/ DELOITTE & TOUCHE LLP

Boston, Massachusetts
July 27, 2000